Does RITUXIMAB Cause Febrile neutropenia? 6,382 Reports in FDA Database

Q: Does RITUXIMAB cause Febrile neutropenia?

6,382 reports of Febrile neutropenia have been filed with the FDA for RITUXIMAB, representing 3.6% of all RITUXIMAB adverse event reports.

Q: How dangerous is Febrile neutropenia from RITUXIMAB?

Of 6,382 reports, 1,011 (15.8%) resulted in death and 3,685 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 6,382 reports of Febrile neutropenia have been filed in association with RITUXIMAB (Rituxan). This represents 3.6% of all adverse event reports for RITUXIMAB.

6,382

Reports of Febrile neutropenia with RITUXIMAB

3.6%

of all RITUXIMAB reports

1,011

Deaths

3,685

Hospitalizations

How Dangerous Is Febrile neutropenia From RITUXIMAB?

Of the 6,382 reports, 1,011 (15.8%) resulted in death, 3,685 (57.7%) required hospitalization, and 709 (11.1%) were considered life-threatening.